申请人:Merck Sharpe & Dohme Ltd.
公开号:US05410049A1
公开(公告)日:1995-04-25
Compounds of formula (I), and salts and prodrugs thereof ##STR1## wherein: R.sup.1 is H, certain optionally substituted C.sub.1-6 alkyl, or C.sub.3-7 cyclocalkyl; R.sup.2 represents a group ##STR2## wherein X is O, S or NR.sup.8 where R.sup.8 is H or C.sub.1-4 alkyl; R.sup.3 is C.sub.1-6 alkyl, halo or NR.sup.6 R.sup.7 ; R.sup.4 is C.sub.1-7 alkyl, C.sub.3-7 cycloalkyl, C.sub.4-7 cycloalkylalkyl or optionally substituted aryl; n is 0, 1, 2 or 3; are CCK and/or gastrin receptor antagonists. They and compositions thereof are useful in therapy.
公式(I)的化合物,以及它们的盐和前药##STR1##其中:R.sup.1是H,某些可选地取代的C.sub.1-6烷基,或C.sub.3-7环烷基;R.sup.2代表一个组##STR2##其中X是O,S或NR.sup.8,R.sup.8是H或C.sub.1-4烷基;R.sup.3是C.sub.1-6烷基,卤素或NR.sup.6 R.sup.7;R.sup.4是C.sub.1-7烷基,C.sub.3-7环烷基,C.sub.4-7环烷基烷基或可选地取代的芳基;n是0, 1, 2或3;是CCK和/或胃泌素受体的拮抗剂。它们和它们的组合物在治疗中是有用的。